Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-30 @ 10:20 AM
Study NCT ID:
NCT05829434
Status:
WITHDRAWN
Last Update Posted:
2024-02-12
First Post:
2023-03-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS
Sponsor:
Uwe Platzbecker
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-22
First Submit QC Date:
None
Study First Post Date:
2023-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-09
Last Update Post Date:
2024-02-12
Last Update Post Date Type:
ACTUAL